GLP-1 Receptor Agonist
  1. Home
  2. Ozempic
  3. GLP-1 Receptor Agonist

GLP-1 Receptor Agonist

GLP-1 Receptor Agonist is a class of prescription medications used to improve blood glucose control in adults with type 2 diabetes and, for certain formulations, support chronic weight management. These therapies work by mimicking the action of the naturally occurring GLP-1 hormone to regulate glucose metabolism. They are available in injectable and oral formulations depending on the active ingredient and treatment requirements.

BUY NOW

Category

GLP-1 Receptor Agonists are designed to activate glucagon-like peptide-1 receptors, helping enhance glucose-dependent insulin secretion, reduce glucagon release, slow gastric emptying, and promote satiety. This therapeutic class includes medications available as subcutaneous injections through prefilled pens and as oral tablets for selected active ingredients. Manufactured under stringent pharmaceutical quality standards, GLP-1 receptor agonist therapies provide reliable medication delivery and support individualized diabetes management plans. GLP-1 Receptor Agonists should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name GLP-1 Receptor Agonist
Therapeutic Class Glucagon-Like Peptide-1 Receptor Agonist
Available Dosage Forms Injection Pens, Oral Tablets
Route of Administration Subcutaneous Injection / Oral
Therapeutic Use Type 2 Diabetes Management, Weight Management (Product Dependent)
Storage As Per Product Label

Product Also Known As

GLP-1 Receptor Agonist, GLP-1 Injection Therapy, GLP-1 Diabetes Medicine, Semaglutide Therapy, Tirzepatide Therapy, Injectable GLP-1 Medication, Diabetes Management Injection